Search for: "Teva Pharmaceutical Industries Ltd." Results 1 - 20 of 164
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
17 Mar 2014, 7:31 am by Pete Strom
Teva Pharmaceuticals Agrees to Pay Settlement in Medicaid Fraud Case Teva Pharmaceuticals Industries, Ltd, which manufactures generic drugs, recently agreed to pay $27.6 million to settle Medicare and Medicaid fraud charges that the company gave kickbacks to a Chicago psychiatrist to prescribe the pharmaceutical manufacturer’s generic antipsychotic, Clozapine. [read post]
22 Jul 2008, 3:36 am
By Sherri Oslick -- In a transaction merging two major players in the generic pharmaceutical arena, Teva Pharmaceutical Industries Ltd. and Barr Pharmaceuticals, Inc. announced late last week that they have entered into an agreement by which Teva will acquire Barr for $7.46 billion plus the assumption of $1.5 billion in debt. [read post]
21 Nov 2017, 1:25 pm by Overhauser Law Offices, LLC
Indianapolis, Indiana – Attorneys for Plaintiff, Eli Lilly and Company of Indianapolis, Indiana, filed suit in the Southern District of Indiana alleging that Defendants, Actavis LLC of Parsippany, New Jersey; Teva Pharmaceuticals USA of North Wales, Pennsylvania; and Teva Pharmaceutical Industries, Ltd. of Petach Tikva, Israel infringed its rights in United States Patent No. 7,772,209 (“the ’209 patent”) for… [read post]
4 Dec 2011, 8:46 am by Eric Guttag
The doctrines of “secret prior art” and “inherency” both merged in the case Teva Pharmaceutical Industries Ltd. v. [read post]
15 Oct 2014, 2:49 pm by Bloomberg
Teva Pharmaceutical Industries Ltd. got a mixed reception at a U.S. [read post]
19 Jan 2010, 1:05 pm by Varun R. Chhonkar
Pfizer Inc. has filed a civil suit against the generic drug manufacturer Teva Pharmaceutical Industries Ltd. for infringement of US patent for antibiotic drug Zyvox. [read post]
20 Jan 2015, 4:23 pm by Richard M.
Supreme Court early this week overturned a Court of Appeals ruling that invalidated a patent by Teva Pharmaceutical Industries Ltd. on a multi-sclerosis drug (Copaxone), offering the drug manufacturer a chance to stall generic competitors. [read post]
25 Sep 2008, 4:23 am
By Donald Zuhn -- Last week, Teva Pharmaceutical Industries Ltd. announced that the European Commission's Directorate General for Enterprise and Industry has granted the company a marketing authorization for its human granulocyte colony stimulating factor (G-CSF) product. [read post]
30 Aug 2011, 5:18 am by Lawrence B. Ebert
The Mylan case is Teva Pharmaceuticals Industries Ltd. v. [read post]
18 Oct 2009, 5:42 pm
Teva Pharmaceutical Industries Ltd. issued a press release last week discussing the abbreviated new drug application (ANDA) containing a Paragraph IV certification for COPAXONE ® (glatiramer acetate injection), filed by Mylan Pharmaceuticals Inc. [read post]
27 Apr 2010, 10:12 am by Mark Zamora
The Food and Drug Administration said it found "significant" manufacturing violations at Teva Pharmaceutical Industries Ltd. [read post]
7 Sep 2007, 3:03 am
Teva/IVAX may have lost on Lexapro, but Friday's a brand new day and stock traders are already looking to Teva's chances on launching a generic version of Wyeth's Protonix.AP reported on Friday, Sept. 7: Teva Pharmaceutical Industries Ltd. shares edged higher Friday as investors wondered if the company will soon launch a generic version of Wyeth's Protonix.On Thursday, a U.S. [read post]
11 Mar 2012, 8:16 pm by Reproductive Rights
Bloomberg: Teva Pharmaceutical Seeks to Intervene in Plan B Lawsuit, by Thom Weidlich: Teva Pharmaceutical Industries Ltd. [read post]
20 Jan 2015, 8:40 am by Associated Press
Overturning the Federal Circuit, the Supreme Court on Tuesday sided with Teva Pharmaceutical Industries Ltd. in the company's high-profile patent dispute with rival firms over the top-selling multiple sclerosis drug Copaxone. [read post]
26 Oct 2012, 5:12 pm by Mandour & Associates
IPNews® - GlaxoSmithKline LLC and Teva Pharmaceutical Industries Ltd. were accused in a new class action in New Jersey federal court on Thursday of striking illegal deals to delay the entry of generic versions of Glaxo's epilepsy drug Lamictal to the market until Glaxo's patent for it expired. [read post]
26 Nov 2007, 9:02 pm
., King Pharmaceuticals, Inc., and Teva Pharmaceutical Industries Ltd. announced that U.S. subsidiaries of Astellas, along with Item Development AB and King have signed settlement agreements with respect to U.S. [read post]
13 Oct 2014, 8:46 pm by Patent Docs
Mylan Pharmaceuticals Inc. et al. 1:14-cv-00167; filed October 7, 2014 in the Northern District of West Virginia • Plaintiffs: Teva Pharmaceuticals USA, Inc.; Teva Pharmaceutical Industries, Ltd.; Teva Neuroscience, Inc.; Yeda Research and Development Co., Ltd. [read post]
8 May 2014, 7:50 pm by FDABlog HPM
District Court for the District of Columbia, Teva Pharmaceutical Industries Ltd. and Teva Neuroscience, Inc. [read post]
1 Nov 2011, 6:30 am by Lawrence B. Ebert
The US Supreme Court denied cert in the Temodar case thus allowing Merck & Co. to block Teva Pharmaceutical Industries Ltd. from selling a generic form of the brain-cancer drug Temodar until 2013. [read post]